Staar Surgical shares are trading lower after Morgan Stanley downgraded the stock from Equal-Weight to Underweight and lowered its price target from $50 to $37.
Portfolio Pulse from Benzinga Newsdesk
Staar Surgical shares are trading lower after Morgan Stanley downgraded the stock from Equal-Weight to Underweight and lowered its price target from $50 to $37.
July 15, 2024 | 10:42 am
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Staar Surgical shares are experiencing a decline following a downgrade by Morgan Stanley from Equal-Weight to Underweight, with a reduced price target from $50 to $37.
The downgrade by a major financial institution like Morgan Stanley, along with a significant reduction in the price target, is likely to negatively impact investor sentiment and lead to a short-term decline in Staar Surgical's stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100